Health
Final Results from REPRISE III: Long-Term Stroke Risk after TAVR for Severe Aortic Stenosis – DocWire News
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results…
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results from the REPRISE III randomized trial, which assessed the Lotus Valve transcatheter aortic valve replacement (TAVR) system…
Continue Reading
-
Noosa News24 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News23 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News13 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News22 hours agoMissing man, Maroochydore – Queensland Police News